Literature DB >> 7797114

Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine.

J C Atherton1, A Cockayne, M Balsitis, G E Kirk, C J Hawkey, R C Spiller.   

Abstract

Treatment of Helicobacter pylori infection with amoxycillin is known to reduce the bacterial load to undetectable levels, while not eradicating the infection. It seems, therefore, that bacteria escape treatment at a 'sanctuary site'. This study examined whether such a site existed in the gastric antrum, body, or fundus. Twenty two patients with H pylori infection and duodenal ulcer disease were treated for one week with amoxycillin (500 mg three times a day) and cimetidine (800 mg at night). Before treatment, H pylori was detected throughout all stomachs, and 13C-urea breath testing at least 28 days after treatment confirmed that eradication of H pylori had occurred in no patients. While under treatment, H pylori was sought by conventional methods and by polymerase chain reaction assay and was found in the gastric fundus in 13 of 22 subjects, in the body in 10 of 22, and the antrum in three of 22: the difference between fundus and antrum was significant (p < 0.01). The continued antral infection in three subjects may have resulted from generalised treatment failure as two of three had H pylori detected throughout the stomach, and these two had compiled relatively poorly with treatment. This study suggests that amoxycillin and cimetidine are relatively effective at clearing H pylori from the gastric antrum, but that escape from treatment may occur in the gastric body, and especially the fundus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797114      PMCID: PMC1382667          DOI: 10.1136/gut.36.5.670

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

Review 1.  The who's and when's of therapy for Helicobacter pylori.

Authors:  D Y Graham; G M Börsch
Journal:  Am J Gastroenterol       Date:  1990-12       Impact factor: 10.864

2.  Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals.

Authors:  S A Ho; J A Hoyle; F A Lewis; A D Secker; D Cross; N P Mapstone; M F Dixon; J I Wyatt; D S Tompkins; G R Taylor
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Campylobacter-like organisms in the stomach of patients and healthy individuals.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error.

Authors:  A Morris; M R Ali; P Brown; M Lane; K Patton
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

6.  Two-week eradication regimen for metronidazole-resistant Helicobacter pylori.

Authors:  R P Logan; P A Gummett; J J Misiewicz; Q N Karim; M M Walker; J H Baron
Journal:  Aliment Pharmacol Ther       Date:  1993-04       Impact factor: 8.171

7.  Short report: high-dose omeprazole and amoxycillin in the treatment of Helicobacter pylori-associated duodenal ulcer.

Authors:  R Collins; S Beattie; H X Xia; C O'Morain
Journal:  Aliment Pharmacol Ther       Date:  1993-06       Impact factor: 8.171

8.  Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.

Authors:  Y Glupczynski; A Burette; M Labbe; C Deprez; M De Reuck; M Deltenre
Journal:  Am J Gastroenterol       Date:  1988-04       Impact factor: 10.864

9.  Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease.

Authors:  G Bode; P Malfertheiner; H Ditschuneit
Journal:  Scand J Gastroenterol Suppl       Date:  1988

10.  Topographic association between active gastritis and Campylobacter pylori colonisation.

Authors:  E Bayerdörffer; H Oertel; N Lehn; G Kasper; G A Mannes; T Sauerbruch; M Stolte
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

View more
  8 in total

Review 1.  A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy.

Authors:  U Peitz; A Hackelsberger; P Malfertheiner
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

2.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

Review 3.  Diagnostic methods for Helicobacter pylori detection and eradication.

Authors:  A F Goddard; R P H Logan
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

4.  The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin.

Authors:  E A Marcus; N Inatomi; G T Nagami; G Sachs; D R Scott
Journal:  Aliment Pharmacol Ther       Date:  2012-09-25       Impact factor: 8.171

Review 5.  Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.

Authors:  P Richardson; C J Hawkey; W A Stack
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

6.  Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.

Authors:  Sander J O Veldhuyzen van Zanten; Tassia Kolesnikow; Vincent Leung; Jani L O'Rourke; Adrian Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 7.  What are appropriate end-points for Helicobacter pylori eradication in the treatment of duodenal ulcer?

Authors:  M P Williams; R E Pounder
Journal:  Drugs       Date:  1998-07       Impact factor: 9.546

8.  Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.

Authors:  Wenming Wu; Yunsheng Yang; Gang Sun
Journal:  Gastroenterol Res Pract       Date:  2012-07-05       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.